This IS great news, Bumper, and I only hope that the AMAZON

New Post Public Reply Private Reply Replies (1) Message Board
Jaime Rodriquez

This IS great news, Bumper, and I only hope that the AMAZON stock people are able to get the job done! Just after I first found this news article, and I forget now how I did ''happen on to it'' in just fishing around one day, I tried posting the same on the SRGE LIE-HUB stock forum, as an innocuous FWIW2A type of public post to none, because she & so many of her cohorts in crime had so completely over taken the SRGE forum, via negatively  bashing in the way that they are INFAMOUS for doing. Needless to say, I was promptly, and I mean PROMPTLY completely & permanently banned for ''personal attack'', and  the post had been promptly deleted also. The which all just goes to prove that lie-hub most definitely has an agenda, the which is to get your money out of your pockets & into theirs, as also into the pockets of their ''minions'' who are willing to sell their souls for their 30 pieces of silver, like as one of their favorite bashers accused old Jaime of doing, if you can swallow that one! If anyone wants to know just who that particular lie-hub basher was who sent me that particular PM, shoot me a PM here on the IHO forum, and I'll let you know who it is, so that you, too, can know at least another one of the lie-hub players that you should avoid at your peril not to. Unless you don't care to be sure about just who you are getting your info from. For then it doesn't matter, does it? That's why anymore, I TRY REALLY HARD TO  WELL KNOW JUST WHO THE POSTERS ARE THAT I AM FOLLOWING! And that just takes some time & skill to get good at it! Otherwise just too many gullible sheep out there, just like I used to be, who trust in the wrong people, and thus lose 'mucho dinero'! Just as I used to!

Now, I realize this is a long post, but all of the above, plus what Bumper posted is well complimented by what I said in the following post, if you will take the time to read it! So, PLEASE REMEMBER! ''CAVEAT EMPTOR''! (note: that other post now follows)


Posted On: 03/15/2013 1:18:53 PM
Posted By:  Jaime Rodriquez
Re: jspax7 #9379

Hello, jspax! In my opinion, FOR SURE, probably all of the administators & too many of the mods & too many of the players consciously & premeditatedly KNOW EXACTLY WHAT THEY ARE DOING in a nefarious & unscrupulous way, and so, on that basis, are without excuse. I also now strongly believe that the official lie-hub administrators &/or other 'officials' behind the scenes, are most likely in collusion with the huge shorting interests, both naked & legal, such as KNIGHT CAPITAL & E-TURD, as also any unscrupulous financiers such as BIG APPLE or GREEN TREE, as also any naked shorters with whom they may have to do, as also minny-poo, without any doubt, etc, etc. And as of now, all of these huge shorting interests, I am convinced, at least personally, that they all (probably) have 'their' moles who are willing to aid & abet them via the SEC, FINRA & THE DTCC. And again to say it, not all of them, of these various organizations, but too many of them! For it is no coincidence how many of these micro cap companies are completely destroyed via ''the whole grey stock market scheme'', cellar boxing, & bankruptcy laws, the which 'RULES OF WHICH' are the direct result of that supposed 'good & honest federal agency ''for the safety & good of the AMERICAN PEOPLE! HAH! What a sad joke! Now, all of the above, IMO, and after 3 years of being a premium member of the ihub net work, was provoked by what you said in the following:

4. Liehub is condoning, even perpetrating the posting (of the bashers & liars, etc, for ''THEIR OWN REASONS). So, once again I say: 'CAVEAT EMPTOR'!


KMA Global Solutions International, Inc. (KMAG) Stock Research Links

KMAG Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 308

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 9

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 26

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 78

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 321

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading

Top 5 Most Recently Viewed Articles

BioSyent Inc. to Announce Q3 Financial Results This Month

Updated Category News Views 189

BioSyent Inc. to Announce Q3 Financial Results BioSyent Inc., a prominent player in the specialty pharmaceutical industry, is preparing to release its financial results for the third quarter and year-to-date period. This important announcement is scheduled for November 20, prior to the market opening. The report will cover the company's performance for the three and nine...

Continue Reading
Dr. Ryan Egeland Joins Solventum as Chief Medical Officer

Updated Category News Views 381

Solventum Welcomes Dr. Ryan Egeland as New CMO Solventum, a pioneering healthcare company, recently announced the appointment of Dr. Ryan Egeland, MD, as their Chief Medical Officer. In this significant role, Dr. Egeland will lead the Global Medical and Clinical Affairs team, amplifying clinician and patient voices within the organization. Fostering Collaboration and...

Continue Reading
MiningToken Revolutionizes Cryptocurrency With AI Power

Updated Category News Views 186

Introducing MiningToken's Innovative AI Cloud Mining Service Bitcoin and Ethereum are experiencing remarkable market dynamics as Bitcoin persists in a bullish trend and Ethereum has gained notable ground recently. As global interest in cryptocurrencies grows, effective mining strategies are crucial for profitability. Amidst rising operational costs, many individuals seek...

Continue Reading
Saluda Medical's EVA™ Sensing Technology Approved in Europe

Updated Category News Views 111

Saluda Medical Achieves Regulatory Milestone with EVA™ Technology Saluda Medical, Inc. (ASX:SLD) has made significant strides in the medical device industry by achieving CE certification for its next-generation EVA™ Sensing Technology. This advancement not only marks a major endorsement in Europe but also is recognized in Australia. Following FDA approval in December...

Continue Reading
ReadPartner Inc. Unveils Revolutionary AI Tool to Combat Misinformation

Updated Category News Views 291

ReadPartner Inc. Launches AI Feature to Tackle Misinformation ReadPartner Inc., a leader in AI-driven media intelligence solutions, is excited to announce the upcoming launch of a groundbreaking digital security feature named ProfileScreen. This innovative tool aims to address the pressing issue of misinformation that plagues social media platforms. The ProfileScreen...

Continue Reading